(Q31110444)

28 June 2017

title

Combinatorial library of indinavir analogues: replacement for the aminoindanol at P2'. (English)

1 reference

28 June 2017

1 reference

Subharekha Raghavan

1

1 reference

28 June 2017

Zheng Yang

2

1 reference

28 June 2017

Ralph T Mosley

3

1 reference

28 June 2017

William A Schleif

4

1 reference

28 June 2017

Lori Gabryelski

5

1 reference

28 June 2017

David B Olsen

6

1 reference

28 June 2017

Mark Stahlhut

7

1 reference

28 June 2017

Lawrence C Kuo

8

1 reference

28 June 2017

Emilio A Emini

9

1 reference

28 June 2017

Kevin T Chapman

10

1 reference

28 June 2017

James R Tata

11

1 reference

28 June 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

28 June 2017

number of pages

4

1 reference

Bioorganic & Medicinal Chemistry Letters

inferred from page(s)

published in

1 reference

28 June 2017

volume

12

1 reference

28 June 2017

issue

20

1 reference

28 June 2017

page(s)

2855-2858

1 reference

HIV protease: a novel chemotherapeutic target for AIDS.

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900632-7

7 January 2021

Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900632-7

7 January 2021

Protease inhibitors: current status and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900632-7

7 January 2021

Virological and clinical implications of resistance to HIV-1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900632-7

7 January 2021

Resistance to human immunodeficiency virus type 1 protease inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900632-7

7 January 2021

Role of pharmacokinetics in the discovery and development of indinavir

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900632-7

7 January 2021

Hepatic and intestinal metabolism of indinavir, an HIV protease inhibitor, in rat and human microsomes. Major role of CYP3A

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900632-7

7 January 2021

Recursive deconvolution of combinatorial chemical libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900632-7

7 January 2021

Solid phase synthesis of indinavir and its analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900632-7

7 January 2021

Combinatorial diversification of indinavir: in vivo mixture dosing of an HIV protease inhibitor library

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900632-7

7 January 2021

A combinatorial library of indinavir analogues and its in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900632-7

7 January 2021

Non-active site changes elicit broad-based cross-resistance of the HIV-1 protease to inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900632-7

7 January 2021

L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900632-7

7 January 2021

10.1016/S0960-894X(02)00632-7

Identifiers

DOI

1 reference

28 June 2017

1 reference